Medizinische Universität Graz - Research portal
Brezinsek Hans-Peter |
Presentations at scientific and public conferences
Brezinsek, HP
Update Immunologie: Was – Wann - Wo?
UPDATE PSORIASIS; SEP 18, 2024; Klagenfurt, AUSTRIA. 2024.
[Poster]
Brezinsek, HP
Autoimmundiagnostik/ ANA/ dsDNA, etc.
Fortbildungsveranstaltung des Herz Jesu Krankenhaus ; APR 18, 2024; Wien, AUSTRIA. 2024.
[Oral Communication]
Brezinsek, HP
Tauchen, in Zeiten von Covid-19 und Long-Covid
Taucherarzt-Workshop; MAR 10-22, 2024; Male, Malediven. 2024.
[Oral Communication]
Brezinsek, HP
Analyse des Gelenkspunktates (Synoviaanalyse)
Infiltrationskurs 2024; JAN 26-27; Graz, AUSTRIA. 2024.
[Oral Communication]
Brezinsek, HP
Langzeit Depletion der B-Zellen.
MS in Motion 2024
; MAY 03-04;2024; Vienna, AUSTRIA. 2024.
[Oral Communication]
Brezinsek, HP
Nebenwirkungsmanagement bei Immuntherapien -
Rheumatologische Nebenwirkungen
3. Wiener Patientenmanagementtag
; MAY 23, 2024; Vienna, AUSTRIA. 2024.
[Oral Communication]
Reisch, M; D'oracio, M; Pollheimer, M; Stradner, M; Thiel, J; Brezinsek, H
Ein Patient mit einer IgG4-assoziierten Erkrankung und einer MPO-Vaskulitis: 2 eigenständige seltene Erkrankungen oder doch ein Overlap?
ÖGR Jahrestagung 2024; NOV 28-30, 2024; Wien, AUSTRIA. 2024.
[Poster]
Reisch, M; D'orazio, M; Pollheimer, M; Stradner, M; Brezinsek, H; Thiel, J
IgG4-related disease or ANCA-associated vasculitis?
Central European Congress for Rheumatology; DEC 5-7, 2024; Ljubljana, SLOVENIA. 2024.
[Oral Communication]
Stradner, M; Monedeiro, F; Zuegner, E; Prietl, B; Oberhuber, M; Khalil, M; Magnes, C; Brezinsek, HP; Libiseller, A; Pieber, T
Comparative Immuno-Metabolomics Shows Singular Changes in Systemic Lupus Erythematosus Metabolic Phenotype Induced by T-Cell Activation
ARTHRITIS RHEUMATOL. 2024; 76: 3647-3648.-ACR Convergence 2024; NOV 15-19, 2024; Washington, USA.
Web of Science
Zügner, E; Monedeiro, F; Prietl, B; Stradner, M; Brezinsek, HP; Stanzer, S; Franz, J; Mattersdorfer, K; Schimek, D; Prugger, EM; Magnes, C;
Sourij, H; Pieber, T
Differentiation of metabolic phenotypes in peripheral blood mononuclear cells from patients with systemic lupus erythematosus and healthy individuals
Jahrestagung der Österreichischen Gesellschaft für Rheumatologie; NOV 29-DEC 2, 2023; Viena, AUSTRIA. 2023.
[Oral Communication]
Brezinsek, HP
Vasculitis mimics“
Rheumatag Steiermark; May 14, 2022; Graz, AUSTRIA. 2022.
[Oral Communication]
Brezinsek, HP
Tauchen und Covid; Update 2022
Tauchmedizin-Workshop 2022; MAR 19-28, 2022; Nautilus Two, Malediven. 2022.
[Oral Communication]
Brezinsek, HP
Immun-induzierte Rheumatologische Nebenwirkungen
Immuntherapien in der Uroonkologie
; JUN 21, 2022; Vienna, AUSTRIA. 2022.
[Oral Communication]
Brezinsek, HP; Blesl, A
Wann braucht der Rheumatologe den Gastroenterologen? Rheuma-Gastro: der gemeinsame Patient.
Wachauer Rheumatag; APR 23, 2022; Spitz a.d. Donau, AUSTRIA. 2022.
[Oral Communication]
D'orazio, M; Daher, M; Lackner, A; Kielhauser, S; Zenz, S; Gretler, J; Thiel, J; Brezinsek, HP; Furst-Moazedi, F
ABATACEPT AS THERAPY OPTION IN SYSTEMIC SCLEROSIS (SSC) PATIENTS AFTER YEARS OF GRAZER- PROTOCOL TREATMENT- OUR EXPERIENCE
ANN RHEUM DIS. 2022; 81: 1493-1493.-EULAR; JUN 1-4, 2022; Copenhagen, Denmark.
Doi: 10.1136/annrheumdis-2022-eular.4711
[Poster]
Web of Science
FullText
FullText_MUG
D'orazio, M; Lackner, A; Zenz, S; Haidmayer, A; Gretler, J; Kielhauser, S; Brezinsek, HP; Moazedi-Fürst F
Transthoracic lung sonography (LUS) – useful surveillance tool in systemic sclerosis associated interstitial lung disease.
Annals of Rheumatic Diseases. 2022; 81(S1):758-759.-EULAR 2022 – Annual European Congress of Rheumatology; JUN 1-4, 2022; Kopenhagen, DANMARK.
Doi: 10.1136/annrheumdis-2022-eular.4430
[Poster]
Web of Science
FullText
FullText_MUG
Dreo, B; Prietl, B; Kofler, S; Pfeifer, S; Sourij, H; Moazedi-Fürst, F; Kreuzer, S; D'Orazia, M; Zenz, S; Thiel, J; Stradner, MH; Brezinsek, HP
Rituximab does not alter expression of co-stimulation marker CD19 on B cells in Systemic Sclerosis patients
Supplementay Issue of Annals of Rheumatic Diseases. 2022; 81(1):1144-1145.-EULAR 2022 - Annual European Congress of Rheumatology; JUN 1-4 2022; Copenhagen.
Doi: 10.1136/annrheumdis-2022-eular.768
Web of Science
FullText
FullText_MUG
Brezinsek, HP
Synoviaanalyse
4. Rheumatologisch-Orthopädischer Qualitätszirkel
Die Synovia-bernsteinfarbene Kostbarkeit oder Trübsal; MAY 12, 2021; Graz. 2021.
[Keynote lecture]
Brezinsek, HP
Impfen und Basistherapie
Add on zum Österreichischen Rheumatag; MAR 24, 2021; Vienna, AUSTRIA. 2021.
[Onlinepräsentation]
Brezinsek, HP
Immunologische Targets in der Rheumatologie
Stand Alone Facetten der Rheumatologie; OCT 21, 2021; Graz, AUSTRIA. 2021.
[Oral Communication]
Brezinsek, HP
Differentialdiagnose der MS - Hilfestellung aus dem Labor
Immunologische Parameter
20 Jahre Differentialdiagnose der MS:
Rückschau, Standortbestimmung, Zukunftsausblick; OCT 8-9, 2021; Graz, AUSTRIA. 2021.
[Oral Communication]
Brezinsek, HP
Covid-19-Pandemie.
Auswirkung auf die Tauchtauglichkeits-Untersuchung
Taucherarzt Workshop
ÖGTH & GTÜM; APR 13 - 23, 2021; Male, MALEDIVEN. 2021.
[Oral Communication]
Brezinsek, HP; Blesl, A
Interdisziplinäres Duett: Rheumatologie und Gastroenterologie im Erfahrungsaustausch
Überschneidungen in der Pathophysiologie
Therapiekonzepte - Gemeinsamkeiten und Erkenntnisse
Jahrestagung der Österreichischen Gesellschaft für Rheumatologie und Rehabilitation; NOV 25-27, 2021; Vienna, AUSTRIA. 2021.
[Oral Communication]
Habenbacher, M; Zenz, S; Lackner, A; Bosch, P; Stradner, M; Brezinsek, H; Moazedi-Fürst, F
Eine retrospektive Auswertung der TNFi-Therapieabbrüche aufgrund von Exazerbation einer interstitiellen Lungenerkrankung bei Rheumatoider Arthritis PatientInnen (von 2005 bis 2019)
https://link.springer.com/content/pdf/10.1007/s41970-021-00175-5.pdf. 2021; -Jahrestagung der österreichischen Gesellschaft für Rheumatologie; NOV 25-27, 2021; VIENNA, AUSTRIA.
[Poster]
Brezinsek, HP
Symptomatische Abklärung: das geschwollene Gelenk.
Rheuma Kollegium - Innovation und Praxis; OCT 2, 2020; Vienna, Austria. 2020.
[Oral Communication]
Brezinsek, HP
JAKi in der Praxis: Erfahrungsaustausch anhand von Patientenfällen.
Österreichische Gesellschaft für Rheumatologie & Rehabilitation
Jahrestagung
; NOV 26 - 28, 2020; Vienna, AUSTRIA. 2020.
[Onlinepräsentation]
[OPEN ACCESS]
Brezinsek, HP
Pathogenese der humoralen Immundefekte.
Österreichische Gesellschaft für Rheumatologie & Rehabilitation
Jahrestagung
; NOV 26 - 28, 2020; Vienna, AUSTRIA. 2020.
[Onlinepräsentation]
Brezinsek, HP
Au, ein Gelenk ist geschwollen! Was tun?
Wachauer Rheumatag ; APR 25, 2020; Vienna, Austria. 2020.
[Oral Communication]
Brezinsek, HP
Analyse des Gelenkspunktates.
Infiltrationskurs 2020; JAN 31 - FEB 01, 2020; Graz, AUSTRIA. 2020.
[Oral Communication]
Brezinsek, HP
Treat to Target – Theorie und Praxis aus der Rheumatologie.
INFLAMMATION SUMMIT 2020; SEP 11-12, 2020; Linz. 2020.
[Oral Communication]
Brezinsek, HP
Xeljanz bei Rheumatoider Arthritis.
Österreichische Gesellschaft für Rheumatologie & Rehabilitation
Jahrestagung; NOV 26 - 28, 2020; Vienna, AUSTRIA. 2020.
[Onlinepräsentation]
Brezinsek, HP
Komedikation in der immunologischen Therapie.
Österreichische Gesellschaft für Rheumatologie & Rehabilitation
Jahrestagung
26. – 28. November 2020; NOV 26 - 28, 2020; Vienna, AUSTRIA. 2020.
[Onlinepräsentation]
Brezinsek, HP
Bewegungsapparat und Hirn.
SYMPOSIUM 2020 Goes Virtual
Das Hirn ist keine Insel – Wechselbeziehung mit anderen Organsystemen und äußeren Einflüssen ; NOV 23, 2020; Graz, AUSTRIA. 2020.
[Onlinepräsentation]
[Science to Public]
Brezinsek, HP
Übersicht über das adaptive Immunsystem.
Zentrale Fortbildung für ApothekerInnen
Immunologie und SARS-CoV-2 – große Herausforderung durch kleines Viru; NOV 7, 2020; Vienna, AUSTRIA. 2020.
[Onlinepräsentation]
Brezinsek, HP
Komorbiditäten bei Biologika-Therapie aus rheumatologischer Sicht.
Netzwerk Biologika - SICHERHEITSPROFILE UND KOMORBIDITÄTEN; OCT 10, 2020; Vienna, AUSTRIA. 2020.
[Oral Communication]
Dreo, B; Prietl, B; Kofler, S; Sourij, H; Lackner, A; Moazedi-Furst, F; D'orazio, M; Stradner, M; Graninger, W; Brezinschek, HP
ABATACEPT ALTERS THE FREQUENCY OF IMMUNOREGULATORY AND EFFECTOR T CELL SUBPOPULATIONS IN RHEUMATOID ARTHRITIS.
ANN RHEUM DIS. 2020; 79: 225-225.-Annual European Congress of Rheumatology (EULAR); JUN 03, 2020; ELECTR NETWORK.
Doi: 10.1136/annrheumdis-2020-eular.4894
[Onlinepräsentation]
Web of Science
FullText
FullText_MUG
Zenz, S; Dreo, B; Prietl, B; Kofler, S; Sourij, H; Lackner, A; D'orazio, M; Brickmann, K; Gretler, J; Furst-Moazedi, F; Stradner, M; Graninger, W; Brezinsek, HP
DRUG DEPENDENT ALTERATIONS IN B-CELL REPERTOIRE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH LOW DISEASE ACTIVITY.
ANN RHEUM DIS. 2020; 79: 1369-1369.-Annual European Congress of Rheumatology (EULAR); JUN 03, 2020; ELECTR NETWORK.
Doi: 10.1136/annrheumdis-2020-eular.4412
[Poster]
Web of Science
FullText
FullText_MUG
Brezinschek, HP
ANA Diagnostics
SGR-SSR_Kongressprogramm_2019. 2019; -Jahreskongress der
Schweizerischen Gesellschaft für Rheumatologie SGR; SEP 5-6, 2019; Interlaken, SCHWEIZ.
[Oral Communication]
FullText
Brezinschek, HP
No way ohne IT-Unterstützung in der Praxis? Zur praktischen Umsetzung von OMERACT und T2T
Jahrestagung der Österreichischen Gesellschaft für Rheumatologie &
Rehabilitation; NOV 28-29, 2019; Vienna, AUSTRIA. 2019.
[Oral Communication]
D‘Orazio, M; Lackner, A; Zenz, S; Kielhauser, S; Gretler, J; Brezinsek, HP;
Haidmayer, AM; Brickmann, K; Graninger, W; Moazedi-Fürst, F
Thickness of the pleura decreases significantly during therapy with rituximab and mycophenolate mofetil in systemic sclerosis
J. Miner. Stoffwechs. Muskuloskelet. Erkrank.. 2019; 26(4):120-120.-Jahrestagung der Österreichischen Gesellschaft für Rheumatologie &
Rehabilitation; NOV 28-29, 2019; Vienna, AUSTRIA.
[Poster]
Dreo, B; Husic, R; Bosch, P; Lackner, A; Graninger, W; Fessler, J; Brezinsek, HP; Stradner, M
STAT signaling profiles in peripheral leucoyctes stratify patients with rheumatoid arthritis
J. Miner. Stoffwechs. Muskuloskelet. Erkrank.. 2019; 26(4):108-108.-Jahrestagung der Österreichischen Gesellschaft für Rheumatologie &
Rehabilitation; NOV 28-29, 2019; Vienna, AUSTRIA.
[Poster]
Dreo, B; Prietl, B; Kofler, S; Sourij, H; Lackner, A; Furst-Moazedi, F; D'Orazio, M; Stradner, M; Graninger, W; Brezinsek, HP
RITUXIMAB SIGNIFICANTLY DIMINISHES CD86+B CELLS IN SYSTEMIC SCLEROSIS
ANN RHEUM DIS. 2019; 78: 1212-1213.-Annual European Congress of Rheumatology (EULAR); JUN 12-15, 2019; Madrid, SPAIN.
Doi: 10.1136/annrheumdis-2019-eular.8047
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Dreo, B; Prietl, B; Kofler, S; Sourij, H; Lackner, A; Moazedi-Fuerst, F; D'Orazio, M; Stradner, M; Graninger, W; Brezinschek, HP
Negative Immune Checkpoint Molecules on T Regulator Cells Distinguish RA, SLE and Healthy Controls
ARTHRITIS RHEUMATOL. Arthritis Rheumatol. 2019. 2019; 71(S 10):-2019 ACR/ARP Annual Meeting; NOV 8-13, 2019; Atlanta, USA.
[Poster]
Web of Science
Dreo, B; Prietl, B; Kofler, S; Sourij, H; Lackner, A; Moazedi-Fürst, F; D‘Orazio, M; Stradner, M; Graninger, W; Brezinsek, HP
Expression of distinct negative immune checkpoint molecules
characterizes T regulatory cells in RA, SLE and healthy controls
J. Miner. Stoffwechs. Muskuloskelet. Erkrank.. 2019; 26: 105-105.-Jahrestagung der Österreichischen Gesellschaft für Rheumatologie & Rehabilitation; NOV 28-29, 2019; Vienna, AUSTRIA.
[Poster]
Dreo, B; Prietl, B; Kofler, S; Sourij, H; Lackner, A; Moazedi-Fürst, F;
D‘Orazio, M; Stradner, M; Graninger, W; Brezinsek, HP
Rituximab treatment significantly reduces circulating CD86+ B cells in systemic sclerosis
J. Miner. Stoffwechs. Muskuloskelet. Erkrank.. 2019; 26(4):107-107.-Jahrestagung der Österreichischen Gesellschaft für Rheumatologie &
Rehabilitation; NOV 28-29,2019; Vienna, AUSTRIA.
[Poster]
Zenz, S; Dreo, B; Lackner, A; Prietl, B; Kofler, S; Sourij, H; Moazedi-Fuerst, F; D'Orazio, M; Stradner, M; Graninger, W; Brezinschek, HP
Diminished Memory B-cells in Systemic Lupus Erythematosus Patients with Low Disease Activity
ARTHRITIS RHEUMATOL. Arthritis Rheumatol. 2019; 71(S 10):-2019 ACR/ARP Annual Meeting; NOV 8-13, 2019; Atlanta, USA.
[Poster]
Web of Science
Zenz, S; Dreo, B; Prietl, B; Kofler, S; Sourij, H; Lackner, A; Moazedi-
Fürst, F; D‘Orazio, M; Stradner, M; Graninger, W; Brezinsek, HP
Diminished Memory B-cells in Systemic Lupus Erythematosus
Patients with Low Disease Activity
J. Miner. Stoffwechs. Muskuloskelet. Erkrank.. 2019; 26(4):106-106.-Jahrestagung der Österreichischen Gesellschaft für Rheumatologie &
Rehabilitation; NOV 28-29, 2019; Vienna, AUSTRIA.
[Poster]
Brezinschek, HP
Update Impfungen
Jahrestagung der Österreichschen Gesellschaft für Rheumatologie und Rehabilitation; NOV 29 - DEC 1, 2018; Wien, AUSTRIA. 2018.
[Oral Communication]
Brezinschek, HP
Synoviaanalyse
Infiltrationskurs; JAN 19-20, 2018; Graz, AUSTRIA. 2018.
[Keynote lecture]
Brezinschek, HP
Kryoglobuline und Kälteagglutinine
Jahrestagung der Österreichischen Gesellschaft für Rheumatologie und Rehabilitation; NOV 29 - DEC 1, 2018; Wien, AUSTRIA. 2018.
[Oral Communication]
Brezinschek, HP
Praktisches Management
Klinik und krankheitsrelevante Score
Psoriasisarthritis, Kollagenosen
Jahrestagung der Wissenschaftlichen Vereinigung Sterische Dermatologie; JUN 22-23, 2018; Graz, AUSTRIA. 2018.
[Oral Communication]
Brezinschek, HP
Small Molecules
Jahrestagung der Wissenschaftlichen Vereinigung Steirische Dermatologie; JUN 22-23, 2018; Graz, AUSTRIA. 2018.
[Oral Communication]
D'Orazio, M; Fliesser, E; Moazedi-Furst, F; Stradner, M; Kielhauser, S; Fessler, J; Brezinschek, HP
Characterization of CD20+T Cells in Patients with Systemic Sclerosis
ARTHRITIS RHEUMATOL. 2018; 70: -Annual Congress of the American College of Rheumatology; OKT 20-24, 2018; Chicago, USA.
[Poster]
Web of Science
Monica D'Orazio, Elisabeth Fliesser, Florentine Moazedi-Fürst, Martin Stradner, Sonja Kielhauser, Johannes Fessler and Hans-Peter Brezinschek
Surface characterization and funktional feature of cd 20 t cells in systemic sclerosis
ÖGR; 2018.
[Poster]
Valentin, T; Stelzl, E; Kessler, HH; Krause, R; Zollner-Schwetz, I; Prattes, J; Wunsch, S; Fruhwald, F; Brezinschek, HP; Flick, H
Detection of Pneumocystis jiroveci DNA in HIV-uninfected patients: a single center experience
WIEN KLIN WOCHENSCHR. 2018; 130: 265-265.
[Poster]
Web of Science
FullText
Brezinschek, HP
Synviaanalyse
Infiltrationskurs; JAN 20-21, 2017; Graz, AUSTRIA. 2017.
[Keynote lecture]
Brezinschek, HP; Kielhauser, S; Graninger, W; Moazedi-Furst, F
Safety and Efficacy of Long-Time Intensified Rituximab Treatment in Patients with Systemic Sclerosis
ARTHRITIS RHEUMATOL. 2017; 69: -ACR; Washington, USA.
[Oral Communication]
Web of Science
Prietl, B; Kofler, S; Stanzer, S; Brezinschek, HP; Münzker, J; Pieber, TR; Sourij H
Response to IL-2-signaling in Tregs is specifically impaired in type 1 diabetes
Proceedings of the 53rd Annual Meeting of the European Association for the Study of Diabetes. 2017; -53rd Annual Meeting of the European Association for the Study of Diabetes; Sept 11-15, 2017; Lisbon, Portugal.
[Poster]
Prietl, B; Kofler, S; Stanzer, S; Brezinsek, H; Munzker, J; Pieber, T; Sourij, H
Response to IL-2 signalling is specifically impaired in type 1 diabetes
DIABETOLOGIA. 2017; 60: S204-S204.-53rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 11-15, 2017; Lisbon, PORTUGAL.
[Poster]
Web of Science
Brezinschek, HP
Checkpoint-Therapie und SAutoimmunität
Jahrestagung der Österreichischen Gesellschaft für Rheumatologie und Rehabilitation; DEC 1-3, 2016; Vienna, AUSTRIA. 2016.
[Oral Communication]
Brezinschek HP
Update: JAK inhibitors
Congress Alpe Adria Rheumatology 2016; MAY 20-21, 2016; Pörtschach, AUSTRIA. 2016.
[Oral Communication]
Brezinschek HP
Haut, Darm und Gelenke
Konstruktive Fallkritik bei Biologika
Streitgespräche - Falldiskussionen mit Dermatologen, Rheumatologen, Gastroenterologen und Psychiatern.; Apr 29, 2016; Graz. 2016.
[Oral Communication]
Brezinschek HP
Monarthritis - Ein geschwollenes Gelenk und dann?
14. Wachauer Rheumatag; APR 23, 2016; Spitz and der Donau. 2016.
[Oral Communication]
Brezinschek HP
1x1 der der Biologicals in der Allgemeinpraxis
Fortbildungsveranstaltung der Ärztekammer Steiermark; MAR 16, 2016; Graz. 2016.
[Keynote lecture]
Brezinschek HP
Autoimmunität - Der Anfang vom Ende einer Immunonkologischen Therapie?
Immun-Onkologisches Symposium 2016; JAN 30, 2016; Salzburg. 2016.
[Oral Communication]
Brezinschek, HP
Immunonkologie und Autoimmunerkrankungen
Jahrestagung der Österreichischen Gesellschaft für Pneumologie; OCT 15-17, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Brezinschek, HP
02. Dezember 2015, Journalistenworkshop und Fortbildungsveranstaltung U-Boot Krankheiten
Fortbildungsveranstaltung U-Boot-Krankheiten; DEC 2, 2015; Vienna, AUSTRIA. 2015.
[Keynote lecture]
Brezinschek, HP
Spondyloarthritis: Diagnostik & Therapie
Fortbildungsveranstaltung; Nov 25, 2015; Krems. 2015.
[Keynote lecture]
Brezinschek, HP
Morbus Bechterew
5. Rheuma Day; FEB 21, 2015; Vienna, AUSTRIA. 2015.
[Keynote lecture]
Brezinschek, HP
Management der RA nach malignen Erkrankungen
Osteologie 2015; MAR 12-15, 2015; Berlin, GERMANY. 2015.
[Oral Communication]
Brezinschek, HP
Synviaanalyse
Infiltrationskurs 2015; JAN 23-24, 2015; Graz, AUSTRIA. 2015.
[Keynote lecture]
Brezinschek, HP; Fürst-Moazedi, F; Kielhauser, S; Stradner, M; Graninger, WB
Rituximab-Non-Responders Fail to Down Regulate CD19 on Naive B cells
Arthritis Rheum. 2015; 67(S10):-ACR/ARHP Annual Meeting; NOV 6-11, 2015; San Francisco, USA.
[Poster]
Web of Science
Stradner, MH; Dejaco, C; Brickmann, K; Graninger, WB; Brezinschek, HP
High plasmablast frequency and lymphocyte count
define populations unresponsive to rituximab
in rheumatoid arthritis
European Congress of Immunology; SEP 6-9, 2015; Vienna, AUSTRIA. 2015.
[Poster]
Stradner, MH; Fessler, J;Dejaco, C;Brickmann, K; Graninger, WB; Brezinschek, HP
A COMBINATION OF CELLULAR BIOMARKERS PREDICTS CLINICAL RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS
Annals of the Rheumatic Disease. 2015; 74(S1):-European Workshop for Rheumatology Research; MAR 5-7, 2015; Budapest, Hungary.
[Poster]
FullText
Woi,R; Kielhauser,S; Lackner,A, Brezinschek,HP; Hermann,J; Gretler,J; Hafner,F; Moazedi-Fürst,F; Graninger,W;
Combined Occupational Therapy Improves Joint Mobility, Proprioception and Quality of Life in Scleroderma Patients.
Journal für Mineralstoffwechsel . 2015; 22(4):120-120.-Österreichische Gesellschaft für Rheumatologie und Rehabilitation ; NOV 26-28, 2015; Vienna, AUSTRIA .
[Poster]
Brezinschek, HP
Sicherheit von Biologikatherapien mit Fokus auf Abatacept
Austauschprogramm für Österreichische Rheumatologen
mit der Rheumatologie der Universitätsklinik Graz; NOV 28, 2014; Graz, AUSTRIA. 2014.
[Keynote lecture]
Brezinschek, HP
Medikamentöse Therapie der SpA
Rheumatologie - Update Refresher; MAY 8-9, 2014; Vienna, AUSTRIA. 2014.
[Keynote lecture]
Brezinschek, HP
Arthritis psoriatica
Rheumatologie - Update Refresher; MAY 8-9, 2014; Vienna, AUSTRIA. 2014.
[Keynote lecture]
Brezinschek, HP
Rheumatoid Arthritis
CONGRESS ALPE ADRIA - RHEUMATOLOGY 2014; MAY 16-17, 2014; Pörtschach, AUSTRIA. 2014.
[Keynote lecture]
Brezinschek, HP
Sicherheitsaspekte bei der Biologika-Therapie der RA
Rheumatologie - Update Refresher; MAY 8-9, 2014; Vienna, AUSTRIA. 2014.
[Keynote lecture]
Brezinschek, HP
Psoriasisarthritis – kleine Schwester der RA?
12. Wachauer Rheumatag; April 5, 2014; Spitz an der Donau, AUSTRIA. 2014.
[Keynote lecture]
Brezinschek, HP
Rheumatoide Arthritis
Edukative Tagung; SEP 11, 2014; Graz, AUSTRIA. 2014.
[Keynote lecture]
Breznschek, HP
Impfungen bei Biologikatherapie
Wissenschaftliche Gesellschaft der Ärztinnen und Ärzte
in der Steiermark: Spezielles aus der Rheumatologie
; MAY 22, 2014; Graz, AUSTRIA. 2014.
[Keynote lecture]
Kielhauser S,Bodo K, Moazedi-Fuerst FC,Brickmann K,Hermann J,Gretler J,Brezinschek HP,Graninger WB
Lymphocyte infitrate in skin biopsies of systemic sclerosis patients after successful rituximab therapy
J Miner Stoffwechs 2014. 2014; (4):139-140.-OEGR; dec 4-5,2014; Vienna,Austria.
[Poster]
Kielhauser,S.M; Bodo,K; Moazedi-Fürst, F; Brickmann,K; Hermann,J; Gretler,J; Brezinschek,HP; Graninger,WB;
Lymphocyte Infiltrate in Skin Biopsies of Systemic Sclerosis patients after successful Rituximab Therapy.
Journal für Mineralstoffwechsel. 2014; 21(4):139-139.-ÖGR-Jahrestagung 2014; DEZ 4 - 7, 2014; Vienna, AUSTRIA.
[Poster]
Stelzer, I; Brezinschek, HP; Fuchs, R; Mangge, H; Graninger,W; Demel, U
Intravenous Immunogloglobulin Therapy Affects The Number And The Function Of Immune Cells In Common Variable Immunodeficiency
J Clin Immunol. 2014; 34(Suppl.):S305-S305.-16th Biennial Meeting of the European Society For Immunodeficiencies; OCT 29 - NOV 1, 2014; Prague, CZECH REPUBLIK.
[Poster]
Web of Science
Stelzer, I; Brezinschek, H.P; Fuchs, R; Mangge, H; Graninger,W; Demel,U;
Intravenous Immunogloglobulin Therapy Affects The Number And The Function Of Immune Cells In Common Variable Immunodeficiency
Programm Book. 2014; 184--16th Biennial Meeting of the European Society For Immunodeficiencies; Oct 29- Nov 1, 2014; Prague.
[Poster]
Stelzer,I; Brezinschek, H.P.; Fuchs, R; Mangge, H; Graninger, W; Demel,U.
Intravenous Immunglobulin Therapy Affects the Number and the Function of Immune Cells In Common Variable Immunodeficiency
J Clin Immunol ( 2014) . 2014; 34 (Suppl2): S139-S515.-Esid 2014 Prague; OCT 29-NOV 1, 2014; Prague.
[Poster]
FullText
Stradner, MH; Dejaco, C; Brickmann, K; Graninger, WB; Brezinschek, HP.
BASELINE CD4+ T LYMPHOCYTE COUNT PREDICTS CLINICAL RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS.
Ann Rheum Dis . 2014; 73(S2):892-892.-EULAR; JUN 11-14, 2014; Paris.
FullText
Brezinschek, HP
Pleiotrope Effekte von Tocilizumab
Journal für Mineralstoffwechsel. 2013; 23(1):25-28.-Rheuma Wintersymposium 2013; JÄN 17 20, 2013; Seefeld,AUSTRIA.
[Keynote lecture]
Brezinschek, HP
Chronische Polyarthritis (rheumatoide Arthritis)
Rheumatag Steiermark; MAI 13,2013; Graz, AUSTRIA. 2013.
[Oral Communication]
Brezinschek, HP
Biomarker für Biologika
Tagung der Wissenschaftliche Gesellschaft der Ärzte Steiermark; NOV 21,2013; Graz, AUSTRIA. 2013.
[Keynote lecture]
Brezinschek, HP
Reisen mit Rheuma
Rheuma Days; Jän 25-26, 2013; Vienna, AUSTRIA. 2013.
[Keynote lecture]
Brezinschek, HP
Vaskulopathie der inneren Organe
24. Grazer Fortbildungstage; OKT 7-12. 2013; Graz, AUSTRIA. 2013.
[Keynote lecture]
Brezinschek, HP
Reaktive Arthritis - Gibt es die?
11. Wachauer RHEUMATAG; APR 20, 2013; Spitz an der Donau, AUSTRIA. 2013.
[Keynote lecture]
Brezinschek, HP
Sicherheit von Biologikatherapien
Clinical Exchange Program; DEZ 6, 2013; Graz, AUSTRIA. 2013.
[Keynote lecture]
Brezinschek, HP
Rituximab bei anderen Autoimmunerkrankungen
Journal für Mineralstoffwechsel. 2013; 23(1):25-28.-Rheuma Wintersymposium; JÄN 17 20, 2013; Seefeld,AUSTRIA.
[Keynote lecture]
Brezinschek,HP
Gelenkschwellungen - Es muss nicht immer RA sein
19. RHEUMASYMPOSIUM AKTUELLE RHEUMATOLOGIE
Frühjahrstagung der ÖGR; FEB 9, 2013; Linz, AUSTRIA. 2013.
[Keynote lecture]
Kielhauser SM, Moazedi-Fuerst FC, Brickamnn K,Hermann J,Brezinschek HP,graninger WB
Rituximab for systemic sclerosis:Arrest of PDprogression in 5 cases
J Miner Stoffwechs. 2013; 20(4):153-153.-ÖGR; Nov ,28-30; Vienna.
[Poster]
Martinelli, E; Angerpointner, K; Pichler, K; Fischerauer, SF; Kraus, T; Ferlic, P; Brezinsek, HP; Zötsch, S; Weinberg AM
Immunological response to bone injuries and imlpantation of a biodegradable polymer
Proceedings of the Euro BioMat conference 2013 Program and Abstract book. 2013; -Euro BioMAT 2013; APRIL 23 - 24, 2013; Weimar, GERMANY.
[Oral Communication]
Puchner, R; Brezinschek, H; Herold, M; Nothnagl, T; Leeb, B
Quality of care of rural, rheumatoid arthritis patients in Austria
Z RHEUMATOL. 2013; 72: 55-55.
[Oral Communication]
Web of Science
Brezinschek, HP; Rainer, F; Lunzer, R; Graninger, WB
Increased expression of CD95 in B cells of 2nd cycle rituximab non-responders.
Annals of the Rheumatic diseases. 2012; 71: 654-654.-Annual European Congress of Rheumatology EULAR 2012; JUN 6-9, 2012; Berlin, GERMANY.
Brickmann, K; Furst, F; Kielhauser, S; Hermann, J; Brezinsek, HP; Graninger, W
RITUXIMAB IN SEVERE SYSTEMIC SCLEROSIS: AN EXPERIENCE
RHEUMATOLOGY. 2012; 51: I19-I19.-Conference on Excellence in Rheumatology; JAN 25-28, 2012; Madrid, SPAIN.
[Poster]
Web of Science
Fischerauer, SF; Kraus, T; Martinelli, E; Pichler, K; Castellani, C; Celarek, A; Tschegg, E; Uggowitzer, P; Brezinsek, HP; Weinberg, A
Magnesium-based Implants for Osteosynthetic Applications in Children
Journal Club - Abteilung für Rheumatologie und Immunologie; DEZ 20, 2012; Graz, AUSTRIA. 2012.
[Keynote lecture]
Rintelen, B; Sautner, J; Haindl, PM; Mai, HT; Brezinschek, HP; Leeb BF
RADAI-5 REMISSION REPRESENTS 2011 ACR/EULAR PROPOSAL FOR REMISSION WITH HIGH SPECIFICITY.
Annals of the Rheumatic diseases. 2012; 71: 652-652.-Annual European Congress of Rheumatology EULAR 2012; JUN 6-9, 2012; Berlin, GERMANY.
Rintelen, B; Sautner, J; Haindl, PM; Mai, HT; Brezinschek, HP; Leeb BF
CHARACTERISTICS OF PATIENTS ACCORDING TO THE TWO 2011 ACR/EULAR PROPOSALS OF REMISSION IN RHEUMATOID ARTHRITIS
Annals of the Rheumatic diseases. 2012; 71: 652-652.-Annual European Congress of Rheumatology EULAR 2012; JUN 6-9, 2012; Berlin, GERMANY.
Brezinschek, HP
B-Zell Ablation - Biologika im Einsatz außerhalb der Zulassung
Rheuma Wintersymposium ; JAN 20-23, 2011; Seefeld, AUSTRIA. 2011.
[Oral Communication]
Brezinschek, HP
Biologische DMARD`s - Gibt es den idealen Patienten
2. Kärntner Rheuma Symposium; JUN 18, 2011; Klagenfurt, AUSTRIA. 2011.
[Oral Communication]
Brezinschek, HP
Biologika in Rheumatologie und Osteologie
19. Osteoporoseforum; MAY 19-21; 2011; St.Wolfgang, AUSTRIA. 2011.
[Oral Communication]
Brezinschek, HP
Update-ABS Register
Jahrestagung der Österreichischen Gesellschaft für Rheumatologie und Rehabilitation; DEC 1-3, 2011; Vienna, AUSTRIA. 2011.
[Oral Communication]
Brezinschek, HP
Long term experience with MabThera in RA in Austria
MabThera Expert Meeting; JUN 9, 2011; Vienna, AUSTRIA. 2011.
[Keynote lecture]
Brezinschek, HP
ACR Review: Austrian Papers
Rheuma Kollegium; NOV 25, 2011; Vienna, AUSTRIA. 2011.
[Oral Communication]
Brezinschek, HP;
ACR-Review: Austrian Papers.
?. 2011; 20-22.-Rheuma Kollegium - von der Universität in die Praxis; NOV 25, 2011; Vienna, Austria.
[Oral Communication]
Brezinschek, HP; Hagspiel, V; Demel, U; Gradwohl, G; Graninger, WB
B-Cell Subsets in Patients with Common Variable or Selective Immunodeficiency
Jahrestagung der Österreichischen Gesellschaft für Allergologie und Immunologie; SEP 15-17,2011; Graz, AUSTRIA. 2011.
[Poster]
Brezinschek, HP; Rainer, F; Brickmann, K; Lunzer, R; Graninger W
EULAR RESPONSE AND B CELL ANALYSIS BY HIGH-SENSITIVE FLOWCYTOMETRY - THE AUSTRIAN B-CELL SURVEILLANCE (ABS) STUDY.
Annals of the Rheumatic diseases2011; -Annual European Congress of Rheumatology EULAR 2011
; May 25 28, 2011; London, United Kingdom.
[Oral Communication]
Brezinschek, HP; Rainer, F; Brickmann, K; Lunzer, R; Graninger, WB
Clinical Response and B Cell Analysis by High-Sensitive Flowcytometry after the Second Course of Rituximab
ARTHRITIS RHEUM. 2011; 63(10):S497-S497.-ACR Annual Scientific Meeting; NOV 4-9, 2011; Chicago, USA.
[Poster]
Web of Science
Brezinschek,HP
Einfluß von Autoantikörper auf das Therapieansprechen
Jahrestagung der Österreichischen Gesellschaft für Rheumatologie und Rehabilitation; DEC 1-3, 2011; Vienna, AUSTRIA. 2011.
[Oral Communication]
Ferlic, P; Fischerauer, SF; Angerpointer, K; Brezinsek, HP; Weinberg, A
Phagocytic activity after implantation of bioresorbable implants in rats
Proceedings of the ZMF Doctoral Day 2011. 2011; -ZMF Doctoral Day; Nov 4, 2011; Graz, AUSTRIA.
[Poster]
Kielhauser, SM; Fuerst, FC; Brickmann, K; Hermann, J; Brezinschek, HP; Graninger WB
Rituximab in severe systemic sclerosis- an experience
Wiener Klinsche Wochenschrift. 2011; 123(17):A68-A68.-ÖGIM ; Oct 5- 7,2011; Innsbruck,Austria.
[Poster]
Web of Science
Kielhauser, SM; Fuerst, FC; Brickmann, K; Tripolt, NJ; Zechner, PM; Scheidl, S; Lutfi, A; Gretler, J; Graninger, WB
Pulmonary echography in systemic sclerosis
Wiener klinsche Wochenschrift. 2011; 123(17):A69-A69.-ÖGIM; Oct ,5-7 2011; Inssbruck,Austria.
[Poster]
Web of Science
Kielhauser SM, Fuerst FC,Hermann J, Brezinschek HP,Graninger WB
Effect of Rituximab in ssevere systemic sclerosis
Wiener Klinische Wochenzeitschrift. 2011; 123(17):A67-A67.-ÖGIM; 5-7 Oct,2011; Innsbruck,Austria.
[Poster]
Kielhauser SM,Fuerst FC,Brickmann K, Hermann J,Brezinschek HP,Graninger WB
Rituximab: New hope in therapy in severe systemic sclerosis
ÖGR; 1-3 Dec, 2011; Vienna,Austria. 2011.
[Poster]
Kielhauser SM,Fuerst FC,Brickmann K,Hermann J,Brezinschek HP,Scheidl S,Graninger WB
Pulmonary sonography: a new tool to screen pateints with systemic sclerosis for incipient peripheral pulmonary structural changes
ÖGR; 1-3,Dec,2011; Vienna,Autria. 2011.
[Poster]
Stelzer, I; Brezinschek; HP; Fuchs, R; Mangge, H; Graninger, W; Demel, U;
Immunomodulatory effects of intravenous immunoglobulin therapy in common variable immunodeficiency
Annual Meeting of the Austrian Society for Allergology and Immunology; SEP 15-17,2011; Graz, Austria. 2011.
[Poster]
Brezinschek, HP
Kristallarthropathie Update
8. Wachauer Rheumatag; APR 17, 2010; Spitz, AUSTRIA. 2010.
[Keynote lecture]
Brezinschek, HP
Neue Biologika - welche und wozu?
7. Kärntner Rheumatag; JAN 23, 2010; Klagenfurt, AUSTRIA. 2010.
[Oral Communication]
Brezinschek, HP
Impfempfehlungen bei Rheumatoider Arthritis und
Kollagenosen
29. RHEUMATOLOGISCHEN
FORTBILDUNGSTAGUNG; JUN 26, 2010; Saalfelden, AUSTRIA. 2010.
[Oral Communication]
Brezinschek, HP
Arthritis - diagnostisches Vorgehen
41. Jahrestagung der ÖGIM; Sep 29 - OCT 2; Salzburg, AUSTRIA. 2010.
[Oral Communication]
Genger, S; Gründl, K; Holzer, I; Graninger, WB; Brezinschek, HP
EXPRESSION OF CD95+ ON B CELLS IN PATIENTS WITH RHEUMATOID ARTHRITIS
ANN RHEUM DIS2010; 69(S3):667-667.-EULAR Annual Scientific Meeting; JUN 16-19, 2010; Rome, ITALY.
Gradwohl, G; Hagspiel, V; Gründl, K; Graninger, WB; Brezinschek, HP
INCREASED FREQUENCY OF NAÏVE AND TRANSITIONAL B CELLS IN RA-PATIENTS
ANN RHEUM DIS2010; 69(S3):667-667.-EULAR Annual Scientific Meeting; JUN 16-19, 2010; Rome, ITALY.
Gradwohl, G; Hagspiel, V; Gründl, K; Graninger, WB; Brezinschek, HP;
Increased frequency of naive and transitional B Cells in RA-Patients.
[AB0092]2010; 69(3):-EULAR; JUN 16-19, 2010; Rom, ITALY.
[Poster]
Hagspiel V.,Gradwohl G., Demel U., Graninger W., Brezinschek HP.
Diminished naive B cells in patients with selective immunoglobulin deficiences.
Abstract Book of the XIVth Meeting of the European Society for Immunodefieciencies (ESID)2010; 109--XIVth Meeting of the European Society for Immunodeficiencies; Oktober 6-9, 2010; Istanbul.
[Poster]
Haindl, PM; Brezinschek, HP; Herold, M; Rintelen, B; Leeb, BF
INITIAL THERAPY FOR PATIENTS WITH UNDIFFERENTIATED PERIPHERAL INFLAMMATORY ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW
Ann Rheum Dis2010; 69(S3):215-215.-EULAR Annual Scientific Meeting; JUN 16-19, 2010; Rome, ITALY.
[Poster]
Winter, H; Gründl, K; Holzer, I; Graninger, WB; Brezinschek, HP;
The Effects of hyaluronidase of synovial flluid cell analysis
[AB0858] Ann Rheum Dis2010; 69(3):-EULAR; JUN 16-19, 2010; Rom, ITALY.
[Poster]
Brezinschek, HP
B-Zellanalyse unter der Therapie mit Rituximab.
Jahrestagung der Österreichischen Gesellschaft für Rheumatologie und Rehabilitation; NOV 20-21, 2009; Graz. 2009.
[Poster]
Brezinschek, HP
Coxibe und cardiovaskuläre Erreignisse.
Rheuma Wintersymposium 2009; JAN 22-25, 2009; Seefeld in Tirol, AUSTRA. 2009.
[Oral Communication]
Brezinschek, HP
Rheuma kommt selten allein . Rheuma und seine Komorbididäten. Eine Herausforderung für Diagnostik und Behandlung.
Rheumatag Steiermark; MAY 16, 2009; Graz. 2009.
[Oral Communication]
Brezinschek, HP
Je früher, desto besser.
7. Wachauer Rheumatag; APR 17, 2009; Krems, AUSTRIA. 2009.
[Keynote lecture]
Brezinschek, HP
Modifizierter Erkrankungsaktivitätsscore und Fibrinogen zur Beurteilung der Krankheitsaktivität.
Fakten der Rheumatologie. 2009; 2: 9-10.
[Poster]
Brezinschek, HP
Impfung bei rheumatoider Arthritis.
4. aks Sommerschule Why Adam is not Eve; AUG 1-8, 2009; Bregenz, AUSTRIA. 2009.
[Oral Communication]
Brezinschek, HP
Impfempfehlungen für Patienten mit rheumatischen Erkrankungen
Wiener Medizinische Wochenschrift2009; 13: 22-23.-Jahrestagung der Österreichischen Gesellschaft für Rheumatologie und Rehabilitation; NOV 20-21, 2009; Graz.
[Oral Communication]
Brezinschek, HP
Arthritis - Welche Untersuchungen sind sinnvoll?
Universum Innere Medizin2009; 06: 28-29.- 40. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 17-19, 2009; Wien, AUSTRIA.
[Keynote lecture]
Brickmann, K; Yazdani-Biuki, B; Tripolt, N; Thonhofer, R; Graninger, WB; Brezinschek, HP;
Prevalence of antibodies against toxoplasma gondii in patients treated with anti-tnf-alpha therapy.
[AB0167]2009; 68(3):-EULAR; JUN 10-13, 2009; Copenhagen, DENMARK.
[Poster]
Knapp, M; Fuerst, FC; Scheidl, S; Tripolt, N; Hofmann, G; Brickmann, K; Stradner, MH; Yazdani-Biuki, B; Graninger, WG; Brezinschek, HP
Successful Therapy of Rheumatoid Pleural Effusion (RPF) with Rituximab - A Case Report
ÖGR Jahrestagung; Nov 20-21,2009; Graz,Austria. 2009.
[Poster]
yazdani-biuki, B; Brickmann, K; Fuerst, FC; Tripolt, N; Graninger, WB; Brezinschek, HP;
Assesment of disease activity in patients with rheumatoid arthritis with a modified disease score with fibrinogen.
[THU146] Ann Rheum DIs2009; 68(3):-EULAR; JUN 10-13, 2009; Copenhagen, DENMARK.
[Poster]
Brezinschek, HP
Neue Empfehlungen zur Methotrexat-Therapie
Universum Innere Medizin. 2008; -39. Jahrestagung Österreichische Gesellschaft für Innere Medizin; SEP 17-20; Graz.
[Oral Communication]
Brezinschek, HP
Rituximab, die Alternative zum TNF Switsching aktuelle Daten zu
Wirksamkeit und Verträglichkeit
Kongressjournal, Wiener Medizinische Wochenschrift2008; 5(14):14-15.-Jahrestagung der Österreichischen Gesellschaft für Rheumatologie und Rehabilitation; NOV 28-29, 2008; Vienna, AUSTRIA.
[Oral Communication]
Brezinschek, HP
Stellenwert der nicht-steroidalen Antirheumatika in der Rheumatologie
Jahrestagung der Österreichischen Gesellschaft für Rheumatologie und Rehabilitation; NOV 28-29, 2008; Vienna, AUSTRIA. 2008.
[Oral Communication]
Deutsch, AJA; Brezinschek, RI; Brezinschek, HP; Beham-Schmid, C; Neumeister, P
Relapsed MALT Lymphomas Are Associated with a Restricted VH3-30.3 Immunoglobulin VH Gene Repertoire and Are Targeted by Aberrant Somatic Hypermutation.
BLOOD. 2008; 112(11):978-978.-50th Annual Meeting of the American- Society-of-Hematology; DEC 06-09, 2008; San Francisco, CA.
[Poster]
Web of Science
Haindl, PM; Eberl, G; Brezinschek, HP; Rintelen, B; Leeb, BF
PULMONARY TOXICITY OF METHOTREXATE IN RHEUMATOID PATIENTS WITH PRE-EXISTENT LUNG DISORDERS
Ann Rheum Dis 20082008; 67(S II):305-305.-EULAR 2008; JUN 11-14, 2008; Paris, FRANCE.
[Poster]
Leeb, BF; Böttcher, E; Brezinschek, HP; Czerwenka, C.; Herold, M; Hitzelhammer, H; Mayrhofer, F; Puchner, R; Rainer, F; Rintelen, B; Schirmer, M; Stuby, U; Bröll, H
THE USE OF TUMOR NECROSIS FACTOR ALPHA-BLOCKERS IN DAILY ROUTINE - AN AUSTRIAN CONSENSUS PROJECT
Ann Rheum Dis 20082008; 67(S II):606-606.-EULAR 208; JUN 11-14, 2008; Paris, FRANCE.
Brezinschek, HP
Diagnostik der rheumatoiden Arthritis.
Gemeinsamer Kongress Österreichischen Gesellschaft für Laboratoriumsmedizin (ÖGLMKC) und der Deutschen Vereinten Gesellschaften für Klinische Chemie (DGKL); SEP 19-22, 2007; Vienna, AUSTRIA. 2007.
[Keynote lecture]
Brezinschek, HP; Brezinschek, RI; Hermann, J; Brickmann, K; Lipp, R; Linkesch, W; Graninger, WB
REMISSION OF RHEUMATOID ARTHRITIS AFTER TREATMENT WITH 90YTTRIUM IBRITUMOMAB TIUXETAN (ZEVALIN®)
Journal für Mineralstoffwechsel2007; 4: 16--Jahrestagung der Österreichischen Gesellschaft für Rheumatologie und Rehabilitation; NOV 23-24, 2007; Vienna, AUSTRIA.
[Poster]
Brickmann, K; Yazdani-Biuki, B; Holzer, I; Graninger, WB; Brezinschek, HP;
Significant Elevation of Matirx Metalloproteinases 8 and 9 in the synovial fluid of patients with rheumatoid arthritis or gout.
[AB0851] Ann Rheum Dis2007; 66(3):-EULAR; JUN 13-16, 2007; Barcelona, SPAIN.
[Poster]
Brickmann, K; Yazdani-Biuki, BJ; Eibinger, C; Graninger, WB; Brezinschek, HR
Determination of rheumatoid factors (RF) and anti cyclic citruillinated peptide antibodies (anti-CCP) in synovial fluid provides no additional information
ANN RHEUM DIS. 2007; 66: 561-561.-EULAR Annual Scientific Meeting; JUN 13-16, 2007; Barcelona, SPAIN.
[Poster]
Web of Science
Brickmann, KS; Yazdani-Biuki, BJ; Brezinschek, RI; Graninger, WB; Brezinschek, HP
Sequential etanercept and rituximab therapy in patients with active RA-SERRA
ARTHRITIS RHEUM. 2007; 56(12):4278-4278.-ACR Annual Scientific Meeting; NOV 6-11, 2007; Boston, USA.
[Poster]
Web of Science
Brickmann,K; Yazdani-Biuki, B.J; Graninger, W.B; Brezinschek H.P;
Significant elevation of angiogenic factors in synovial fluid of RA-Patients.
[AB0029]. 2007; 66(3):-EULAR; JUN 13-17,2007; Spain.
[Poster]
Chen, LX; Mandell, B; Brezinsek, HP; Schumacher, HR
Pilot Testing of Instruments to Assess Knowledge of Synovial Fluid (SF) Analysis
Arthritis Rheum2007; 56(9):S538--ACR Annual Scientific Meeting ; NOV 6-11, 2007; Boston, USA.
[Oral Communication]
Brezinschek, H; Brickmann, K; Yazdani-Biuki, B; Graninger, W
Sequential Rituximab and Etanercept Treatment in two patients with rheumatoid arthritis
Journal für Mineralstoffwechsel . 13(4):121-121.-Jahrestagung der ÖGR; NOV 24-15, 2006; Vienna, AUSTRIA.
[Poster]
Brezinschek, HP; Dörner, T; Brezinschek, R; Brickmann, K; Yazdani-Biuki, B; Graninger, WB;
Successful sequential rituximab and etanercept treatment in two patients with rheumatoid arthritis.
[AB0173] Ann Rheum Dis2006; 65(3):-EULAR; JUN 21-24, 2006; Amsterdam, NETHERLANDS.
[Poster]
Brickmann, K; Brezinschek, H; Yazdani-Biuki, B; Graninger, W
Prevalence of Anti-citrullinated mutated vimentin (MVC)
Journal für Mineralstoffwechsel . 13(4):121-121.-Jahrestagung der ÖGR; NOV 24-25, 2007; Vienna, AUSTRIA.
[Poster]
Brickmann, K; Yazdani-Biuki, B; Brezinschek, H; Graninger, W
Elevated VEGF Levels in synovial fluid of patients with rheumatoid arthritis or gout.
Journal für Mineralstoffwechsel . 13(4):122-122.-Jahrestagung der ÖGR; NOV 24-25, 2007; Vienna, AUSTRIA.
[Poster]
Brickmann, K; Yazdani-Biuki, B; Brezinschek, H; Graninger, W
Autoantibodies against mutated citrullinated vimentin (Anti-MCV) in the elderly population
Journal für Mineralstoffwechsel . 14(3):122-122.-Jahrestagung der ÖGR; NOV 24-25, 2007; Vienna, AUSTRIA.
[Poster]
Brickmann, K; Yazdani-Biuki, B; Mueller, T; Graninger, WB; Brezinschek, HP;
Anti-mutated-citrullinated-vimentin antibodies (MCV) in psoriatic arthritis.
[AB0492] Ann Rheum Dis2006; 65(3):-EULAAR; JUN 21-24, 2006; Amsterdam, NETHERLANDS.
[Poster]
Brickmann, KP; Yazdani-Biuki, BJ; Graninger, M; Brezinschek, RI; Stoiser, E; Graninger, WB; Brezinschek, HP
Autoantibodies against mutated citrullinated Vimentin (anti-MCV) in the elderly population
ANN RHEUM DIS. 2006; 65: 580-581.-Annual European Congress of Rheumatology (EULAR 2006); JUN 21-24, 2006; Amsterdam, NETHERLANDS.
Web of Science
Yazdani-Biuki, BJ; Brickmann, K; Brezinschek, RI; Muller, T; Graninger, W; Brezinschek, H
The positive predictive value of anti-cyclic citrullinated peptide antibodies for rheumatoid arthritis compared with psoriatic arthritis and chronic lymphocytic B-cell leukemia
ANN RHEUM DIS. 2006; 65: 159-159.-Annual European Congress of Rheumatology (EULAR 2006); JUN 21-24, 2006; Amsterdam, NETHERLANDS.
Web of Science
Brickmann, K;Brezinschek, R; Yazdani-Biuki;B; Brezinschek, HP; Demel, U; Graninger, W;
Rheumatoid Arthritis-specific Autoantibodies in chronic lymphatic B-Cell Leukemia.
[AB0077] 2005; 64(3):-EULAR; JUN 8-11,2005; Vienna, AUSTRIA.
[Poster]
Brickmann, KS; Yazdani-Biuki, BJ; Brezinschek, RI; Mulabecirovic, A; Graninger, WB; Dorner, T; Brezinschek, H
Different reading frame usage of variable heavy chain diversity segments in patients with systemic lupus erythematosus and rheumatoid arthritis
ANN RHEUM DIS 2005 64: 229-229.
[Poster]
Web of Science
Mueller, T; Graninger, WB; Yazdani-Biuki,B; Breinschek, HP; Pilger, E; Brodmann, M;
Is high sensitive C-reactive protein or coeruloplasmin helpful in the diagnosis of giant cell arthritis?.
[AB0170] Ann Rheum Dis2005; 64(3):-EULAR; JUN 8-11, 2005; Vienna, AUSTRIA.
[Poster]
Yazani-Biuki, B; Brezinschek, R; Brickmann, K; Brodmann, M; Pilger, E; Graninger, WB; Brezinschek, HP;
Diminished growth Factor levels in connective tissue disorders compares to Osteoarthritis.
[AB0192] Ann Rheum Dis2005; 64(3):-EULAR; JUN 8-11, 2005; Vienna, AUSTRIA.
[Poster]
Yazdani-Biuki, BJ; Mueller, T; Brezinschek, H; Graninger, WB; Pilger, E; Brodmann, M
Seasonal variation in acute phase proteins in patients with primary Raynaud's phenomenon
ANN RHEUM DIS 2005 64: 300-300.
[Poster]
Web of Science
Mueller, T; Hermann, J; Yazdani-Biuki, B.J; Wohlfahrt, K; Brezinschek, H.P; Mulabecirovic,A; Demel, U; Graninger, WB;
ANA Development following treatment with three different tumour necrosis factor alpha-blocking agents.
[AB0072]2004; 63(3):-EULAR; JUN 9-12; 2004; Berlin, GERMANY.
[Poster]
Yazdani-Biuki, B; Wohlfahrt, K; Mueller, T; Mulabecirovic, A; Brezinschek, RI; Graninger, WB; Brezinschek, HP
A modified disease activity score with fibrinogen as a tool for the assesment of disease activity in patients with rheumatoid arthritis
ARTHRITIS RHEUM 2004 50: S164-S164.
Web of Science
Yazdani-Biuki, BJ; Mulabecirovic, A; Mueller, T; Hermann, J; Graninger, WB; Brezinschek, H
Significant increase of IGG- and IGA-rheumatoid factor in patients with rheumatoid arthritis during prolonged treatment with etanercept
ANN RHEUM DIS 2004 63: 140-140.
[Poster]
Web of Science
Mulabecirovic, A; Yazdani-Biuki, B; Brezinschek, R; Muller, T; Hermann, J; Brezinschek, HP
Superantigen seems to shape the naive synovial tissue B cell repertoire in rheumatoid arthritis
ANN RHEUM DIS 2003 62: 141-141.
Web of Science
Muller, T; Liebscher, B; Yazdani-Biuki, B; Eder, S; Gretler, J; Brezinschek, H; Hermann, J
Efficacy and safety of leflunomide in rheumatoid arthritis patients treated in an outpatient clinic
ANN RHEUM DIS 2003 62: 423-423.
Web of Science
Yazdani-Biuki, B; Bahadori, B; Mulabecirovic, A; Brezinschek, R; Brezinschek, HP
Isoprostane as a marker of disease activity in SLE patients.
ARTHRITIS RHEUM 2003 48: 1488-1488.
Web of Science
Yazdani-Biuki, B; Brezinschek, RJ; Gretler, J; Eder, S; Mueller, T; Hermann, J; Mulabecirovic, A; Krappinger, A; Stadlmaier, E; Uitz, E; Brezinschek, HP
Comparison of antibody titers with sledai, modified SLEDAI and ECLAM in SLE patients
ANN RHEUM DIS 2003 62: 435-435.
Web of Science
Yazdani-Biuki, B; Brezinschek, R; Dorner, T; Jakobi, AM; Hermann, J; Muller, T; Eder, S; Gretler, J; Fuchshofer, A; Brezinschek, HP
Naive B cells in SLE preferentially utilize diversity gene segments in reading frames encoding hydrophobic amino acids
J RHEUMATOL. 2001; 28: 87-87.
Web of Science
Yazdani-Biuki, BJ; Brezinschek, RI; Doerner, T; Jakobi, AM; Maizen, C; Brezinschek, HP
Preferential utilization of D segments in hydrophobic reading frames in antibodies is a specific feature of SLE but not RA or normal B-cells.
ARTHRITIS RHEUM. 2001; 44(9): S76-S76.
Web of Science
Brezinschek, HP; Brezinschek, RI; Lipsky, PE
V-H-specific selection of B cells in the synovial tissue from a patient with rheumatoid arthritis.
ARTHRITIS RHEUM. 2000; 43(9): S77-S77.
Web of Science
Brezinschek, HP; Brezinschek, RI; Lipsky, PE; Frohman, E
B cells in the cerebrospinal fluid from a patient with multiple sclerosis are clonally expanded and highly mutated
NEUROLOGY. 2000; 54(7): A276-A277.
Web of Science
Brezinschek,R; Brezinschek,HP; Eder,S; Jäger,G; Linkesch,W;
Reanalysis of VDJ-arrangements obtained from individual B cells using the germline query.
Onkologie. 2000; 23: 599-599.- ; ; .
[Poster]
Brezinschek,RI; Brezinschek,HP; Eder,S; Bauer,F; Linkesch,W;
Similar molecular features of immunoglobulin heavy chain genes in normal and chronic lymphocytic leukemia B cells.
Onkologie. 2000; 23: 101-101.- ; ; .
[Poster]
Brezinschek, HP; Brezinschek, RT; Foster, SJ; Dorner, T; Farner, NL; Lipsky, PE
Preferential utilization of V-H genes in different B cell subsets obtained from synovial tissue.
ARTHRITIS RHEUM. 1997; 40(9): 1288-1288.
Web of Science
Attrep, J; Brezinschek, HP; Brezinschek, RI; Lipsky, PE
Functional activity of CD40 expressed by activated T cells.
ARTHRITIS RHEUM. 1996; 39(9): 1418-1418.
Web of Science
Attrep, J; Brezinschek, HP; Brezinschek, RI; Lipsky, PE
Regulatory influences of CD40 on T lymphocytes.
FASEB J. 1996; 10(6): 2614-2614.
Web of Science
Brezinschek, HP; Brezinschek, RI; Foster, SJ; Dorner, T; Lipsky, PE
Analysis of the immunoglobulin repertoire of human B-1 (CD5+) B cells.
ARTHRITIS RHEUM. 1996; 39(9): 102-102.
Web of Science
Brezinschek, RI; Brezinschek, HP; Lazarovits, AI; Lipsky, PE; OppenheimerMarks, N
Human endothelial cells express the beta 7 integrin.
ARTHRITIS RHEUM. 1996; 39(9): 41-41.
Web of Science
Brezinschek, RI; Brezinschek, HP; Lazarovitz, AI; Lipsky, PE; OppenheimerMarks, N
Expression of the beta 7 integrin by human endothelial cells.
FASEB J. 1996; 10(6): 1177-1177.
Web of Science
Dorner, T; Brezinschek, HP; Brezinschek, RI; Foster, SJ; Lipsky, PE
Patterns of somatic mutations in human VH-genes.
ARTHRITIS RHEUM. 1996; 39(9): 1508-1508.
Web of Science
ATTREP, J; BREZINSCHEK, HP; BREZINSCHEK, RI; LIPSKY, PE
FUNCTION OF CD40 EXPRESSED ON HUMAN T-LYMPHOCYTES
ARTHRITIS RHEUM. 1995; 38(9): 232-232.
Web of Science
BREZINSCHEK, HP; FOSTER, SJ; BREZINSCHEK, RI; LIPSKY, PE
THE HUMAN-IMMUNOGLOBULIN VARIABLE HEAVY-CHAIN REPERTOIRE
ARTHRITIS RHEUM. 1995; 38(9): 1007-1007.
Web of Science
BREZINSCHEK, HP; LIPSKY, PE
USAGE OF VARIABLE HEAVY-CHAIN GENES BY SINGLE HUMAN B-LYMPHOCYTES
FASEB J. 1994; 8(4): A525-A525.
Web of Science
DOMIATISAAD, R; BREZINSCHEK, HP; LIPSKY, PE
ACTIVATION OF HUMAN B-CELLS BY STAPHYLOCOCCAL ENTEROTOXINS - B-CELL SUPERANTIGENS
FASEB J. 1994; 8(4): A253-A253.
Web of Science
BREZINSCHEK, HP; KROMER, G; FASSLER, R; JAKOBER, R; GAGGL, I; SCHAUENSTEIN, K; WICK, G
DISRUPTION OF IMMUNOENDOCRINE COMMUNICATION IN SPONTANEOUS AUTOIMMUNE-THYROIDITIS
WIEN KLIN WOCHENSCHR. 1988; 100(3): 88-88.
Web of Science
WICK, G; KROMER, G; BREZINSCHEK, H; FASSLER, R; DIETRICH, H; ZIEMIECKI, A
A NEW ENDOGENOUS VIRUS (EV-22) OCCURRING IN OBESE STRAIN (OS) CHICKENS WITH SPONTANEOUS AUTOIMMUNE-THYROIDITIS (SAT)
FASEB J. 1988; 2(6): A1676-A1676.
Web of Science
DOHR, G; BREZINSCHEK, HP; WEIZSACKER, HW
LOCALIZATION OF ELASTIC VESSELS
ANAT ANZEIGER. 1986; 161(2): 128-129.
Web of Science